Developer docs
API playgroundTry for free, no card

Search company profiles

Promimic

Full company profile

uuid0003mx4

Namestring
Promimic
Websiteurl
promimic.com
Company typeenum
Private
Founded yearint
2004
Descriptiontext

Promimic is a Sweden-based biomaterials company founded in 2004 and headquartered in Göteborg. It develops proprietary nanotechnology surface modification technology that is applied to medical implants—most notably 3D-printed PEEK devices—to enhance osseointegration, the process by which an implant integrates with surrounding bone tissue, and to accelerate patient healing. The company's core technology is a nanoscale surface treatment rather than a finished implant product; Promimic does not sell implants under its own brand but instead delivers its technology as an embedded input into partner-manufactured devices.

The company's business model is B2B technology licensing to medical device manufacturers. Promimic generates revenue through licensing and royalty arrangements under which OEM partners integrate its surface modification process into their implant manufacturing workflows. Its most prominent disclosed partnership is with Curiteva, an Alabama-based manufacturer specializing in 3D-printed PEEK implants. In May 2025, Promimic expanded this relationship to extend beyond spine into cranial and orthopedic applications, broadening its addressable surgical market.

Promimic's customer base consists of medical device manufacturers producing implants that benefit from enhanced bioactivity and tissue integration. Pricing is not publicly disclosed, and the company maintains a small operational footprint (11–50 employees) led by CEO Magnus Larsson, founder/CTO Per Kjellin, co-founder Martin Andersson, CCO Ulf Brogren, and Marketing & Sales Director Diana Mårdbrink. Capital has historically come from Swedish institutional investors including Chalmers Ventures AB, Almi Invest, and Karolinska, with disclosed funding totaling approximately $8.1M across four rounds between 2011 and 2019.

Short descriptiontext

Promimic is a Sweden-based biomaterials company developing proprietary nanotechnology surface modifications that accelerate osseointegration in medical implants, licensing the technology B2B to device manufacturers such as Curiteva for spine, cranial, and orthopedic 3D-printed PEEK applications.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersMölndal, Sweden
HQ citystring
Mölndal
HQ countrystring
Sweden
HQ regionstring
Europe
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
implant surface modification, osseointegration nanotechnology, biomaterial coatings, PEEK implant technology, medical device licensing
Industry3 codes
PRIMARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYIMAAADAG
Medical & Dental 3D Printing Services (patient-specific devices, dental labs)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Services (On-Demand Manufacturing & Service Bureaus)
SECONDARYIMAIAKAM
Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating)
Industrials, Manufacturing & Construction/Industrial Services & Facility Operations/Industrial & Commercial Painting, Coating & Surface Treatment
NAICS code1 code
  • Research and Development in Nanotechnology541713
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Coating, Engraving & Allied Services3470
Product category
Medical Device Surface Modification Technology
No data
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model1 record
1Technology Licensing
TypeLicensing Royalties
Description

Promimic licenses its proprietary surface modification nanotechnology to medical device manufacturers for integration into their implant products. Revenue is generated through licensing agreements with partners like Curiteva for applications in spine, cranial, and orthopedic implants.

orthospinenews.com
Distribution channels1 record

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components4 values
Technology or R&D, Personnel, Operations, Marketing or Sales
GTM typeB2B
B2B
Offering typeServices
Services
Core offering1 text field

Promimic develops and licenses proprietary nanotechnology-based surface modifications that are applied to medical implants — particularly 3D-printed PEEK implants — to make them bioactive and accelerate osseointegration and healing. The company sells its surface treatment technology to medical device manufacturers for integration into spine, cranial, and orthopedic implant products under OEM and licensing arrangements.

Differentiator
Functional benefit
Problem solved
Product overview1 text field

Promimic is a Swedish nanotechnology firm that provides surface modification technology for medical implants. The company offers surface enhancement solutions that promote osseointegration and accelerate healing in 3D-printed PEEK implants for spine, cranial, and orthopedic applications. The specific product names and detailed portfolio could not be extracted as the company website was not accessible during data collection.

Product and service1 record
1Nano Surface Modification Technology for Medical Implants
Partnership1 partner
Strategic tierCoreTypeStrategic or Co-development PartnerAnnounced on2025-05-06
Description

Curiteva, an Alabama-based company specializing in 3D-printed PEEK implants, has expanded its partnership with Promimic to incorporate Promimic's surface modification nanotechnology into its implant technology. The collaboration aims to produce advanced, bioactive implants that promote osseointegration and accelerate healing. The partnership extends their technology application beyond spine to cranial and orthopedic solutions.

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight4 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

SurModics is a U.S.-listed medical device surface modification company offering proprietary coatings (hydrophilic, hemocompatible, drug-eluting) used in vascular, ophthalmic, and other implantable devices. It is comparable to Promimic as a B2B licensor of surface-modification technologies to medical device OEMs, though it operates at much larger scale and across a broader device portfolio.

2Biocoat
TypeDirect peer
Description

Biocoat develops hydrophilic and bioactive coatings for medical devices, including catheter, guidewire, and ophthalmic applications, and licenses its coating technology to OEMs. It is comparable to Promimic because it operates a similar B2B licensing model for surface modification chemistry targeted at medical implants and devices.

TypeDirect peer
Description

Hydromer manufactures and licenses hydrophilic polymer coatings applied to catheters, guidewires, and other medical devices. It is comparable to Promimic as a coatings licensor supplying surface-modification technology to medical device OEMs under similar licensing economics.

TypeDirect peer
Description

DOT GmbH provides biocompatible coating solutions, including diamond-like carbon and functional coatings, used on orthopedic and dental implants and instruments. It is comparable to Promimic because it supplies surface-enhancement coatings specifically engineered to improve osseointegration and biocompatibility of implants.

TypeBroad incumbent
Description

N2 Biomedical offers ion beam and sputter coating services (e.g., titanium niobium nitride, silver, and other thin-film coatings) for orthopedic, spinal, and other medical implants. It is comparable to Promimic as a provider of advanced surface modification coatings used on implantable medical devices.

TypeDirect peer
Description

CAM Bioceramics develops hydroxyapatite and other calcium phosphate coatings used on orthopedic and dental implants to improve bone integration. It is comparable to Promimic because both provide bioactive surface technologies designed to accelerate osseointegration on implantable devices.

TypeDirect peer
Description

Covalon Technologies develops antimicrobial and biocompatible coatings applied to medical devices and wound care products, licensing its surface technologies to medical device manufacturers. It is comparable to Promimic as a medical surface-coating licensor targeting implant and device OEMs.

TypeDirect peer
Description

Vesta (formerly SiO2 Medical Products) provides precision surface treatments and coatings for medical device components, including implants and drug-delivery devices. It is comparable to Promimic as a specialty surface-engineering supplier serving medical implant and device OEMs.

TypeOthers
Description

Innovasis designs and manufactures PEEK-based spinal implant systems and is itself an OEM customer for surface-modification technologies. It is comparable to Promimic's downstream counterparties (e.g., Curiteva) as a 3D-printed and machined PEEK implant manufacturer that could be a candidate adopter of Promimic's technology.

10Orchid Orthopedic Solutions
TypeOthers
Description

Orchid Orthopedic Solutions is a contract manufacturer of orthopedic implants and instruments, including coated and surface-treated devices. It is comparable to Promimic as an adjacent participant in the orthopedic implant supply chain that applies or sources surface enhancements for implants.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat3 records

Each record includes

Type, Details

Key risks6 records

Each record includes

Headline, Details, Source

Key highlights6 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers1 record

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment1 record

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile1 record

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
Yes
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature1 record

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles5 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds5 records

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors4 records

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Promimic

Medical Device Surface Modification Technologypromimic.com

Promimic is a Sweden-based biomaterials company developing proprietary nanotechnology surface modifications that accelerate osseointegration in medical implants, licensing the technology B2B to device manufacturers such as Curiteva for spine, cranial, and orthopedic 3D-printed PEEK applications.

What Promimic does

Promimic is a Sweden-based biomaterials company founded in 2004 and headquartered in Göteborg. It develops proprietary nanotechnology surface modification technology that is applied to medical implants—most notably 3D-printed PEEK devices—to enhance osseointegration, the process by which an implant integrates with surrounding bone tissue, and to accelerate patient healing. The company's core technology is a nanoscale surface treatment rather than a finished implant product; Promimic does not sell implants under its own brand but instead delivers its technology as an embedded input into partner-manufactured devices.

The company's business model is B2B technology licensing to medical device manufacturers. Promimic generates revenue through licensing and royalty arrangements under which OEM partners integrate its surface modification process into their implant manufacturing workflows. Its most prominent disclosed partnership is with Curiteva, an Alabama-based manufacturer specializing in 3D-printed PEEK implants. In May 2025, Promimic expanded this relationship to extend beyond spine into cranial and orthopedic applications, broadening its addressable surgical market.

Promimic's customer base consists of medical device manufacturers producing implants that benefit from enhanced bioactivity and tissue integration. Pricing is not publicly disclosed, and the company maintains a small operational footprint (11–50 employees) led by CEO Magnus Larsson, founder/CTO Per Kjellin, co-founder Martin Andersson, CCO Ulf Brogren, and Marketing & Sales Director Diana Mårdbrink. Capital has historically come from Swedish institutional investors including Chalmers Ventures AB, Almi Invest, and Karolinska, with disclosed funding totaling approximately $8.1M across four rounds between 2011 and 2019.

Promimic firmographics

Firmographics
Name
Promimic
Website
https://promimic.com
Company type
Private
Founded year
2004
Operating status
Operating
Headcount range
11–50 employees
Short description
Promimic is a Sweden-based biomaterials company developing proprietary nanotechnology surface modifications that accelerate osseointegration in medical implants, licensing the technology B2B to device manufacturers such as Curiteva for spine, cranial, and orthopedic 3D-printed PEEK applications.
Ownership category
akta.pro rank

Promimic industry classification

Industry
Product category
Medical Device Surface Modification Technology
NAICS
Research and Development in Nanotechnology (541713)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Coating, Engraving & Allied Services (3470)
akta.pro industry
PRIMARYHLAHAEAJ
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
Healthcare & Life Sciences/Medical Devices & Diagnostics/Implants & Prosthetics (Orthopedic/Neuro/Spine/Dental)
SECONDARYIMAAADAG
Medical & Dental 3D Printing Services (patient-specific devices, dental labs)
Industrials, Manufacturing & Construction/3D Printing/3D Printing Services (On-Demand Manufacturing & Service Bureaus)
SECONDARYIMAIAKAM
Specialty & Functional Coatings (Anti-microbial/Anti-slip/Insulating)
Industrials, Manufacturing & Construction/Industrial Services & Facility Operations/Industrial & Commercial Painting, Coating & Surface Treatment

Keywords

  • Implant surface modification
  • Osseointegration nanotechnology
  • Biomaterial coatings
  • PEEK implant technology
  • Medical device licensing

Where Promimic is headquartered

Location

Headquarters

HQ city
Mölndal
HQ country
Sweden
HQ region
Europe

Offices1 record

Markets served

Promimic business model

Business model
GTM type
B2B
Offering type
Services
Cost components
Technology or R&D, Personnel, Operations, Marketing or Sales

Revenue model

  1. Technology Licensing: Promimic licenses its proprietary surface modification nanotechnology to medical device manufacturers for integration into their implant products. Revenue is generated through licensing agreements with partners like Curiteva for applications in spine, cranial, and orthopedic implants.

Go-to-market motion1 record

Distribution channels1 record

Promimic product offering

Product offering

Core offering

Promimic develops and licenses proprietary nanotechnology-based surface modifications that are applied to medical implants — particularly 3D-printed PEEK implants — to make them bioactive and accelerate osseointegration and healing. The company sells its surface treatment technology to medical device manufacturers for integration into spine, cranial, and orthopedic implant products under OEM and licensing arrangements.

Product overview

Promimic is a Swedish nanotechnology firm that provides surface modification technology for medical implants. The company offers surface enhancement solutions that promote osseointegration and accelerate healing in 3D-printed PEEK implants for spine, cranial, and orthopedic applications. The specific product names and detailed portfolio could not be extracted as the company website was not accessible during data collection.

Differentiator

Problem solved

Functional benefit

Products and services

  • Nano Surface Modification Technology for Medical Implants

Companies that use Promimic

Customer profile

Named customers1 record

Segments1 record

Ideal customer profiles1 record

Promimic technology and API

Technology

Technology focussed Yes

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature1 record

Promimic partnerships and signals

Strategic signal

Partnerships

One partnership is on record.

  • CuritevacoreStrategic or Co-development Partner · 6 May 2025Curiteva, an Alabama-based company specializing in 3D-printed PEEK implants, has expanded its partnership with Promimic to incorporate Promimic's surface modification nanotechnology into its implant technology. The collaboration aims to produce advanced, bioactive implants that promote osseointegration and accelerate healing. The partnership extends their technology application beyond spine to cranial and orthopedic solutions.

Recent moves5 records

Expansion highlights4 records

Promimic competitors and assessment

Company assessment

Broad incumbents

  • SurModics: SurModics is a U.S.-listed medical device surface modification company offering proprietary coatings (hydrophilic, hemocompatible, drug-eluting) used in vascular, ophthalmic, and other implantable devices. It is comparable to Promimic as a B2B licensor of surface-modification technologies to medical device OEMs, though it operates at much larger scale and across a broader device portfolio.
  • N2 Biomedical: N2 Biomedical offers ion beam and sputter coating services (e.g., titanium niobium nitride, silver, and other thin-film coatings) for orthopedic, spinal, and other medical implants. It is comparable to Promimic as a provider of advanced surface modification coatings used on implantable medical devices.

Direct peers

  • Biocoat: Biocoat develops hydrophilic and bioactive coatings for medical devices, including catheter, guidewire, and ophthalmic applications, and licenses its coating technology to OEMs. It is comparable to Promimic because it operates a similar B2B licensing model for surface modification chemistry targeted at medical implants and devices.
  • Hydromer: Hydromer manufactures and licenses hydrophilic polymer coatings applied to catheters, guidewires, and other medical devices. It is comparable to Promimic as a coatings licensor supplying surface-modification technology to medical device OEMs under similar licensing economics.
  • DOT GmbH: DOT GmbH provides biocompatible coating solutions, including diamond-like carbon and functional coatings, used on orthopedic and dental implants and instruments. It is comparable to Promimic because it supplies surface-enhancement coatings specifically engineered to improve osseointegration and biocompatibility of implants.
  • CAM Bioceramics: CAM Bioceramics develops hydroxyapatite and other calcium phosphate coatings used on orthopedic and dental implants to improve bone integration. It is comparable to Promimic because both provide bioactive surface technologies designed to accelerate osseointegration on implantable devices.
  • Covalon Technologies: Covalon Technologies develops antimicrobial and biocompatible coatings applied to medical devices and wound care products, licensing its surface technologies to medical device manufacturers. It is comparable to Promimic as a medical surface-coating licensor targeting implant and device OEMs.
  • Vesta (SiO2 Medical Products): Vesta (formerly SiO2 Medical Products) provides precision surface treatments and coatings for medical device components, including implants and drug-delivery devices. It is comparable to Promimic as a specialty surface-engineering supplier serving medical implant and device OEMs.

Others

  • Innovasis: Innovasis designs and manufactures PEEK-based spinal implant systems and is itself an OEM customer for surface-modification technologies. It is comparable to Promimic's downstream counterparties (e.g., Curiteva) as a 3D-printed and machined PEEK implant manufacturer that could be a candidate adopter of Promimic's technology.
  • Orchid Orthopedic Solutions: Orchid Orthopedic Solutions is a contract manufacturer of orthopedic implants and instruments, including coated and surface-treated devices. It is comparable to Promimic as an adjacent participant in the orthopedic implant supply chain that applies or sources surface enhancements for implants.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat3 records

Key risks6 records

Key highlights6 records

Customer concentration

Promimic financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Promimic leadership team

Management profile

Number of profiles

Profiles5 records

Promimic funding detail

Funding detail

Funding overview

Funding rounds5 records

Investors4 records

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Promimic M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Promimic

What does Promimic do?

Promimic develops and licenses proprietary nanotechnology-based surface modifications that are applied to medical implants — particularly 3D-printed PEEK implants — to make them bioactive and accelerate osseointegration and healing. The company sells its surface treatment technology to medical device manufacturers for integration into spine, cranial, and orthopedic implant products under OEM and licensing arrangements.

Is Promimic a public or private company?

Promimic is a private company. It is classified as venture growth investor backed and is currently operating.

When was Promimic founded?

Promimic was founded in 2004. It employs 11 to 50 people.

Where is Promimic based?

Promimic is headquartered in Mölndal, Sweden, in the Europe region.

How does Promimic make money?

One revenue line is on record: technology Licensing.

Who are Promimic's main competitors?

Broad incumbents on record are SurModics and N2 Biomedical. Direct peers are Biocoat, Hydromer, DOT GmbH, CAM Bioceramics, Covalon Technologies and Vesta (SiO2 Medical Products). Others are Innovasis and Orchid Orthopedic Solutions.

Does Promimic have an API?

No public API is recorded for Promimic.

What industry is Promimic in?

Promimic's product category is Medical Device Surface Modification Technology. Its primary akta.pro industry code is HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial), with a secondary code of IMAAADAG, Medical & Dental 3D Printing Services (patient-specific devices, dental labs). Its NAICS code is 541713 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
TradingViewPRO: Record sales growth and new FDA approvals drive future expansion and strong outlookPromimic AB reported record quarterly sales with 21% growth and strong implant revenue increase in its November 19, 2025 interim report. The company received five new FDA approvals and expanded US processing capacity to support future growth. Promimic maintained a high equity ratio and continues to target annual growth exceeding 25%.OdtmagOrthopedic Device Surface Innovation for IntegrationThe orthopedic device industry is rapidly advancing surface treatments and coatings, such as nanoengineered bioactive layers and diamond-like carbon, to enhance osseointegration, reduce infection risks, and improve implant longevity. Key manufacturers including Promimic, Lincotek Medical, Danco Medical, and Nanovis are deploying these technologies to address clinical challenges like bone integration and bacterial colonization while navigating regulatory requirements. These innovations support the growing demand for minimally invasive devices and additive manufacturing by providing specialized finishing solutions that optimize both functional performance and surgical usability.GlobeNewswireInterim Report - January-June 2025Karolinska Development AB published its interim report for January-June 2025, reporting a net loss of SEK -87.5 million for the period and a net loss of SEK -73.3 million in Q2. The portfolio's fair value fell to SEK 1,384.9 million, down SEK 49.3 million from the previous quarter, mainly due to the divestment of OssDsign shares and share price declines in Modus Therapeutics and Promimic.Ortho Spine NewsCuriteva & Promimic – Bonded By Innovation – Ortho Spine NewsCuriteva, a leader in 3D-printed Trabecular PEEK implant technology, announced an expanded global partnership with Promimic, extending exclusive rights to incorporate Promimic's HAFUSE® surface modification technology on porous PEEK implants for spinal, cranial, and orthopedic applications. The collaboration combines Curiteva's Inspire® technology with Promimic's surface treatment to enhance osseointegration, representing what both companies describe as the world's first 3D-printed, fully interconnected Trabecular PEEK structure. Both companies highlighted the partnership as a significant advancement that could redefine standards across multiple medical specialties.GlobeNewswireKarolinska Developments portfolio company Promimic publishes positive results on reduction of bacteria growth on HAnano SurfacePromimic published positive results showing a 33-46% reduction in bacterial growth on its HAnano Surface implant coating, based on in vitro tests against S. epidermidis and P. aeruginosa. The effect is bacteriostatic, not bactericide, which may reduce bacterial resistance risk. The technology has been applied to over 1.8 million implants.GlobeNewswireKarolinska Developments portfolio company Promimic and Danco Medical form a joint venture for the US-marketPromimic and Danco Medical formed a joint venture for US medical implant processing, with Promimic acquiring 60% of Nano Processing. The deal, completed July 21, is financed with USD 417,750 cash and USD 1,350,000 in Promimic shares. Promimic expects growth and profitability impacts as early as next year.GlobeNewswireKarolinska Development’s portfolio company Promimic presents preclinical results showing decreased bacterial adhesion to implantsPromimic presented preclinical results showing its HAnano Surface coating reduces bacterial adhesion to implants by up to 60%. The study evaluated three pathogenic strains and was presented at the ETPN conference. The technology has been applied to over 700,000 implants in clinical use.GlobeNewswireKarolinska Development’s portfolio company Promimic’s stock starts trading todayPromimic's stock begins trading on Nasdaq First North Growth Market under the short name 'PRO'. The company issued 5 million shares, raising SEK 80 million before costs, fully subscribed. Karolinska Development's stake remains 16.3% after the IPO.GlobeNewswireInterim Report - January-March 2022Karolinska Development published its Q1 2022 interim report, showing a net loss of SEK 29.2 million and a portfolio fair value of SEK 1,279.4 million. The company completed a rights issue subscribed to 76.9%, raising SEK 378 million, and its portfolio company Promimic's IPO was fully subscribed.